As the global economy mends, the 2021 growth of Premature Ejaculation Treatment will have significant change from previous year. According to our (LP Information) latest study, the global Premature Ejaculation Treatment market size is USD million in 2022 from USD 2801.7 million in 2021, with a change of % between 2021 and 2022. The global Premature Ejaculation Treatment market size will reach USD 5303.2 million in 2028, growing at a CAGR of 9.5% over the analysis period.
The United States Premature Ejaculation Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Premature Ejaculation Treatment market, reaching US$ million by the year 2028. As for the Europe Premature Ejaculation Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Premature Ejaculation Treatment players cover Pfizer, Bayer, Menarini, and Lilly, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Premature Ejaculation Treatment market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Antidepressants (SSRIs)
Type 5 Phosphodiesterase Inhibitor
Local Anesthetics
Traditional Chinese Medicine
Ethnic Medicine
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Human Medicine
Veterinary Drugs
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer
Bayer
Menarini
Lilly
Johnson & Johnson
GlaxoSmithKline
Hotan Uighur Pharmaceutical
Sichuan Kelun Pharmaceutical
Guangdong T&K Pharmaceutical Factory
Beijing Tongrentang
Tai Chi Group
Guangzhou Baiyunshan Pharmaceutical
Jiangxi Huiren Pharmaceutical
Jiuzhitang